285 related articles for article (PubMed ID: 38250592)
1. Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant.
Wouldes TA; Lester BM
Front Pediatr; 2023; 11():1305508. PubMed ID: 38250592
[TBL] [Abstract][Full Text] [Related]
2. Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety.
Saloner B; Whitley P; Dawson E; Passik S; Gordon AJ; Stein BD
Addiction; 2023 Aug; 118(8):1549-1556. PubMed ID: 37158468
[TBL] [Abstract][Full Text] [Related]
3. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
[TBL] [Abstract][Full Text] [Related]
4. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
[TBL] [Abstract][Full Text] [Related]
5. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression.
Baldo BA
Arch Toxicol; 2023 Oct; 97(10):2575-2585. PubMed ID: 37537419
[TBL] [Abstract][Full Text] [Related]
6. Signals of increasing co-use of stimulants and opioids from online drug forum data.
Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
[TBL] [Abstract][Full Text] [Related]
7. Opioid Use in Pregnancy.
Tobon AL; Habecker E; Forray A
Curr Psychiatry Rep; 2019 Nov; 21(12):118. PubMed ID: 31734808
[TBL] [Abstract][Full Text] [Related]
8. Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021.
Friedman J; Shover CL
Addiction; 2023 Dec; 118(12):2477-2485. PubMed ID: 37705148
[TBL] [Abstract][Full Text] [Related]
9. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.
Frost MC; Lampert H; Tsui JI; Iles-Shih MD; Williams EC
Addict Sci Clin Pract; 2021 Oct; 16(1):62. PubMed ID: 34635170
[TBL] [Abstract][Full Text] [Related]
10. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
11. Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome.
Lappen JR; Stark S; Bailit JL; Gibson KS
Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100075. PubMed ID: 33345989
[TBL] [Abstract][Full Text] [Related]
12. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
Hughto JMW; Tapper A; Rapisarda SS; Stopka TJ; Palacios WR; Case P; Silcox J; Moyo P; Green TC
Subst Abuse Treat Prev Policy; 2023 May; 18(1):30. PubMed ID: 37217975
[TBL] [Abstract][Full Text] [Related]
13. Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi S; Amato L; Bellisario C; Ferri M; Davoli M
Cochrane Database Syst Rev; 2013 Dec; (12):CD006318. PubMed ID: 24366859
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine Use and Its Correlates among Individuals with Opioid Use Disorder in a Midwestern U.S. City.
Daniulaityte R; Silverstein SM; Crawford TN; Martins SS; Zule W; Zaragoza AJ; Carlson RG
Subst Use Misuse; 2020; 55(11):1781-1789. PubMed ID: 32441178
[No Abstract] [Full Text] [Related]
15. Definitive urine drug test findings in patients prescribed opioids for pain from a large national database.
Guevara MG; LaRue L; Zacharoff KL; Whitley P; Dawson E; Passik SD
J Opioid Manag; 2022; 18(4):361-375. PubMed ID: 36052933
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for preterm birth among gravid individuals receiving buprenorphine for opioid use disorder.
Abdelwahab M; Petrich M; Wang H; Walker E; Cleary EM; Rood KM
Am J Obstet Gynecol MFM; 2022 May; 4(3):100582. PubMed ID: 35123110
[TBL] [Abstract][Full Text] [Related]
17. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
18. Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine - 25 States, July-December 2017 to January-June 2018.
Gladden RM; O'Donnell J; Mattson CL; Seth P
MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(34):737-744. PubMed ID: 31465320
[TBL] [Abstract][Full Text] [Related]
19. Prenatal methamphetamine-impact on the mother and child-a review.
Perez FA; Blythe S; Wouldes T; McNamara K; Black KI; Oei JL
Addiction; 2022 Jan; 117(1):250-260. PubMed ID: 33830539
[TBL] [Abstract][Full Text] [Related]
20. Maintenance agonist treatments for opiate-dependent pregnant women.
Minozzi S; Amato L; Jahanfar S; Bellisario C; Ferri M; Davoli M
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006318. PubMed ID: 33165953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
